Home > Insider Trading > Filing (0000950103-18-003630)

Filing Details

Accession Number:: 0000950103-18-003630
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-21 18:27:51
Reporting Period:: 2018-03-20

Accepted Time:: 2018-03-21 18:27:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1701051	Wideopenwest Inc.	WOW	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1158783	Jeffrey Marcus	C/O Crestview Advisors, L.l.c. 667 Madison Avenue, 10Th Floor New York NY 10065	Yes	No	No	No
1559054	Crestview Advisors, L.l.c.	C/O Crestview Partners 667 Madison Avenue, 10Th Floor New York NY 10065	Yes	No	Yes	No
1608356	P Brian Cassidy	C/O Crestview Advisors, L.l.c. 667 Madison Avenue, 10Th Floor New York NY 10065	Yes	No	No	No
1693578	G. Daniel Kilpatrick	C/O Crestview Advisors, L.l.c. 667 Madison Avenue, 10Th Floor New York NY 10065	Yes	No	No	No
1703027	Crestview Partners Iii Gp, L.p.	C/O Crestview Partners 667 Madison Avenue, 10Th Floor New York NY 10065	Yes	No	Yes	No
1703151	Crestview W1 Holdings, L.p.	C/O Crestview Partners 667 Madison Avenue, 10Th Floor New York NY 10065	Yes	No	Yes	No
1703176	Crestview W1 Te Holdings, Llc	C/O Crestview Partners 667 Madison Avenue, 10Th Floor New York NY 10065	Yes	No	Yes	No
1703177	Crestview W1 Co-Investors, Llc	C/O Crestview Partners 667 Madison Avenue, 10Th Floor New York NY 10065	Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-20	1,306,767	$7.15	26,144,576	No	4	P	Indirect	See Footnotes
Common Stock	Acquisiton	2018-03-21	150,000	$7.58	26,294,576	No	4	P	Indirect	See Footnotes

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnotes
No	4	P	Indirect	See Footnotes

Footnotes

Includes (i) 20,865,918 shares of Common Stock beneficially owned by Crestview W1 Holdings, L.P., (ii) 1,029,448 shares of Common Stock beneficially owned by Crestview W1 TE Holdings, LLC, (iii) 4,379,080 shares of Common Stock beneficially owned by Crestview W1 Co-Investors, LLC and (iv) 20,130 restricted shares of Common Stock granted to Jeffrey A. Marcus, Brian P. Cassidy and Daniel G. Kilpatrick under the Issuers 2017 Omnibus Incentive Plan (the "Plan") that are scheduled to vest on the date of the Issuer's regularly scheduled 2018 annual stockholder's meeting, subject to the terms of the Plan and the applicable award agreement issued thereunder (each of Messrs. Marcus, Cassidy and Kilpatrick have assigned all rights, title and interest in the restricted shares of Common Stock to Crestview Advisors, L.L.C).
Crestview Partners III GP, L.P. and certain of its affiliates may be deemed to have beneficial ownership of the shares of Common Stock held by Crestview W1 Holdings, L.P., Crestview W1 TE Holdings, LLC and Crestview W1 Co-Investors, LLC (collectively, the "Crestview Funds"). Crestview Partners III GP, L.P. exercises voting and dispositive power over the shares of Common Stock held by the Crestview Funds, which decisions are made by the investment committee of Crestview Partners III GP, L.P.
Jeffrey A. Marcus, Brian P. Cassidy and Daniel G. Kilpatrick are each members of the Issuer's board of directors. Each of Messrs. Marcus, Cassidy and Kilpatrick are Partners of Crestview, L.L.C. (which is the general partner of Crestview Partners III GP, L.P.) and Crestview Advisors, L.L.C., which provides investment advisory and management services to certain of the foregoing entities.
Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
This price is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $7.31 to $7.79, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote 5 to this Form 4.